Source: ERS webinar 2020: COVID-19 in patients with rare diseases of the respiratory system
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
DG Sante (European commission), T.O. F. Wagner (Frankfurt/Main, Germany), I. Fajac (Paris, France), M. Kreuter (Heidelberg, Germany), G. Verleden (Leuven, Belgium), M. Humbert (Paris, France), Heymut Omran (Münster, Germany). COVID-19 in patients with rare diseases of the respiratory system. ERS webinar 2020: COVID-19 in patients with rare diseases of the respiratory system

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary diseases in primary immunodeficiency syndromes Source: Respipedia Article Year: 2017 Drug-induced ILD Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders Year: 2007 Fungal VAP Source: Eur Respir Mon 2011; 53: 122-137 Year: 2011 COVID-19: Current Challenges in ILD Source: ERS webinar 2020: COVID-19: Current Challenges in ILD Year: 2020 Complex chronic comorbidities of COPD Source: Eur Respir J 2008; 31: 204-212 Year: 2008 Immundefects, rare pulmonary infections and rare lung diseases Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases Year: 2020 Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals Source: Eur Respir J 2011; 37: 791-799 Year: 2011 Hughes-Stovin syndrome: A case report Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Small airways diseases, excluding asthma and COPD: an overview Source: Eur Respir Rev 2013; 22: 131-147 Year: 2013 Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005 Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Interstital lung diseases: update 2005 Source: Annual Congress 2005 - Clinical year in review Year: 2005 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon Source: Eur Respir J 2012; 39: 669-676 Year: 2012 Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Pulmonary involvement in children with rheumatic diseases Source: International Congress 2016 – Connective tissue disorders Year: 2016 Drug-induced infiltrative lung disease Source: Eur Respir J 2001; 18: 93S-100S Year: 2001 An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context Year: 2013